DiaMedica Therapeutics (DMAC) Share-based Compensation (2017 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Share-based Compensation of $822000.0 for Q1 2026, down 5.19% year-over-year from $867000.0 in Q1 2025, and down 31.04% quarter-over-quarter from $1.2 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Share-based Compensation (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Share-based Compensation history runs 10 years deep, the most recent figure standing at $822000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 5.19% year-over-year to $822000.0; the TTM figure through Mar 2026 stood at $3.8 million (up 54.26% YoY), while the FY2025 annual figure was $10.6 million, up 135.56% from the prior year.
- Share-based Compensation for Q1 2026 stood at $822000.0, down from $1.2 million in the prior quarter.
- The five-year high for Share-based Compensation was $1.2 million in Q4 2025, with the low at $308000.0 in Q1 2022.
- The 5-year median for Share-based Compensation is $456000.0 (2023), against an average of $584588.2.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation plunged 39.73% in 2022, then surged 102.38% in 2025.
- DiaMedica Therapeutics' Share-based Compensation stood at $411000.0 in 2022, then grew by 10.95% to $456000.0 in 2023, then increased by 29.17% to $589000.0 in 2024, then soared by 102.38% to $1.2 million in 2025, then sank by 31.04% to $822000.0 in 2026.
- Business Quant data shows DMAC's Share-based Compensation at $822000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 822,000.00 |
| Mar 31, 2026 | 822,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 771,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 589,000.00 |
| Dec 31, 2024 | 589,000.00 |
| Sep 30, 2024 | 565,000.00 |
| Sep 30, 2024 | 565,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Mar 31, 2024 | 488,000.00 |